Dr Marco Zaki Dr Sari Alhasan Dr Ruchi Shukla Misti McCain Maja Laszczewska et al. | Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma? | 2022 |
|
Marco Zaki Dr Ahmed Mahdi Dr Gillian Patman Anna Whitehead Joao Mauricio et al. | Key features of the environment promoting liver cancer in the absence of cirrhosis | 2021 |
|
Dr Peixun Zhou Dr Alex Blain Alex Newman Dr Masood Zaka Dr Ugo Offor et al. | Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif | 2019 |
|
Dr Peixun Zhou Alex Newman Filbert Adlar Casey Broadbent Dr Alison Blain et al. | Investigation of FOXO1 mutations in paediatric endemic and sporadic Burkitt lymphoma | 2018 |
|
Dr Richard Speight Anna Whitehead Dr Gillian Patman Dr John Mansfield Professor Helen Reeves et al. | Activation of the bile acid receptor, Farnesoid-X Receptor, may reduce Ileal Inflammatory Cytokine expression in an animal model of diet-induced obesity | 2015 |
|
Anna Whitehead Dr Gillian Patman Professor Chris Day Dr Dina Tiniakos Professor Quentin Anstee et al. | Effects of FXR agonist PX20606 on tumour formation in animal models of non-alcoholic fatty liver disease | 2015 |
|
Anna Whitehead Laura Ogle Dr Gillian Patman Dr Ali Anwar Dr Dina Tiniakos et al. | Ras and p-ERK in metabolic syndrome associated Hepatocellular Carcinoma (HCC) | 2015 |
|
Anna Whitehead Dr Gillian Patman Liam Cornell Dr Despina Televantou Professor Nicola Curtin et al. | A Role for DNA Repair Protein Kinase (DNA-PK) in the Progression of Simple Steatosis to Steatohepatitis (NASH)? | 2013 |
|
Dr Gillian Patman Dr Despina Televantou Anna Whitehead Professor Chris Day Professor Fiona Oakley et al. | Mild Steatosis and Impaired Glucose Tolerance are Associated with Liver Cancer Development, While Progression to Nash Increases Number/Size in an Animal Model of NAFLD | 2013 |
|
Dr Gillian Patman Dr Despina Televantou Anna Whitehead Professor Chris Day Professor Alastair Burt et al. | Sulfatase-2 (SULF2) Expressed in Hepatocytes and Stromal Cells Contributes to the Development of Steatosis, the Progression of NAFLD to Fibrosis and the Advancement of Cancer | 2013 |
|